Concepedia

Gregory Cairncross

GC

Statistics

Publications

26

Citations

4.4K

H-Index

20

Active since

1994

Affiliations

University of Calgary(Current)

Western University

Mayo Clinic in Arizona

Mayo Clinic

McGill University

Gregory Cairncross is an author at University of Calgary specializing in medicine, neuro-oncology, and oncology.

Publications per year

1994–2020

26

Publications

26

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

Gregory Cairncross, Meihua Wang, Edward Shaw et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

, , +14

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Gregory Cairncross, Brian Berkey, Edward Shaw et al. · Journal of Clinical Oncology · 2006 · 725 citations

, , +15

Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason et al. · Journal of Clinical Oncology · 2006 · 508 citations

, , +17

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

Gregory Cairncross, David Macdonald, Samuel K. Ludwin et al. · Journal of Clinical Oncology · 1994 · 443 citations

, , +17

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation.

C. Leighton, B. Fisher, Glenn Bauman et al. · Journal of Clinical Oncology · 1997 · 370 citations

, , +17

1–5 of 26